News

NHGRI 2025 Training Meeting

December 12, 2024 - 10:27PM - by Sophie Forman

Funding Announcement: RFA-HG-25-005

November 20, 2024 - 02:36PM - by Sophie Forman

The AnVIL-based R03 funding opportunity I’ve mentioned to many of you recently was just published: https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-25-005.html. The purpose of this announcement is to encourage the genomics research community to leverage data sets available through NHGRI’s AnVIL platform for innovative research and secondary analysis projects. As the NHGRI-designated data repository specified in NOT-HG-24-020, AnVIL makes available large amounts of data, tools and resources generated primarily by NHGRI-funded programs and initiatives.

FY25 Bioethics NOSI is Live

October 31, 2024 - 07:32PM - by Sophie Forman

NIH Seeks to Fund Innovative Research and Capacity Building Efforts Related to Bioethics

NIH, through the Office of Science Policy, is announcing the availability of administrative supplements to support research on bioethical issues that either inform future policy directions or augment bioethics research capacity. For more information, including special areas of interest and application instructions, please see NOT-OD-25-015. Applications will be accepted until 5:00pm (applicant local time) on January 24, 2025.

For more information on prior supplements, see here.

Questions about eMERGE supplements may be directed to Rene Sterling at rene.sterling@nih.gov. Questions about specific Institute/Center/Office research priorities should be directed to the contact listed in the notice. General questions may be sent to SciencePolicy@od.nih.gov.

NOSI: Administrative supplements to active NIH awards to support replication studies using independent contract resources (NOT-RM-24-013)

October 22, 2024 - 03:28PM - by Sophie Forman

Notice of Special Interest (NOSI): Administrative supplements to active NIH awards to support replication studies using independent contract resources

The NIH Common Fund has released a Notice of Special Interest (NOSI) to provide support for preparatory activities to enable replication of impactful biomedical studies by an independent contract research organization (CRO). Applications must identify a preclinical study with high potential impact on public health that is amenable to replication by an independent CRO. The study to be replicated may replicate an experiment, replicate the results of a previous computational analysis, or replicate a demonstration of the capabilities of a novel tool, technology, or method. The study must be able to be completed within the one-year budget period. 

  • Full Text of the Notice of Special Interest (NOSI):  Administrative supplements to active NIH awards to support replication studies using independent contract resources (NOT-RM-24-013).
  • The funding provided by this funding opportunity is not to directly perform replication activities, but to support preparatory activities and engagement with the CRO. The replication studies will be performed by the CRO, and results will not be made public without consent of the original principal investigator(s).
  • Applicants must be requesting administrative support to an active NIH-supported parent award to be eligible under this NOSI.
  • Applications will be accepted starting through November 15, 2024 by 5:00 PM local time of applicant organization.
  • A technical assistance webinar will be held on October 29, 2024 from 4:00-5:00 PM ETUse this link to register.
  • Email Dr. Sahana Kukke and Dr. Michelle Hamlet at CF-Replication@od.nih.govwith any questions. 

Find answers to Frequently Asked Questions (FAQs) on the Replication to Enhance Research Impact Initiative website.


View news archive...